Research News & Publications

2016 International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations: Results of the Montalcino Aortic Consortium

2016 FOXE3 mutations predispose to thoracic aortic aneurysms and dissections

2016 LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections 

2016 The Expanding Clinical Spectrum of Extracardiovascular and Cardiovascular Manifestations of Heritable Thoracic Aortic Aneurysm and Dissection

2016 Multidisciplinary Aortopathy Clinics Should Now Be the Standard of Care in Canada

2015 A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome

2014 Canadian Cardiovascular Society Position Statement on the Management of Thoracic Aortic Disease

2014 Loeys–Dietz syndrome: a primer for diagnosis and management

2014 November 19 Losartan vs Atenolol Study Results: Equal Therapies

2013 CMA International Scientific Meeting

11 Sep 2011: Study Reveals Risk Factor Doubling Chance of Developing Silent Killer

2011 CMA Research Grant Recipient - September 23, 2011

April 2011: Noncanonical TGFB Signaling Contributes to Aortic Aneurysm Progression in Marfan Mice

April 2011: Frightening Risk of Marfan syndrome, and Potential Treatment, Elucidated

Surgical management of aortic root disease in Marfan: a systematic review and meta analysis Jan 2011

Revised Diagnostic Criteria for Marfan syndrome Published in Journal of Medical Genetics Jul 2010

UK Researcher Seeks Couples

BC Children's Hospital Losartan vs. Atenolol Trial is Beginning

Breakthrough in Marfan Research

Update on the Clinical Trial Comparing Atenolol and Losartan